Combinature Biopharm AG was founded in 2000 by scientists and managers, including professors and other members of staff, from the Universities of Freiburg and Tübingen, the Research Institute for Molecular Pharmacology, Berlin, and the German Resource Center for Genome Research, Berlin. The company is located on Berlin´s leading biomedical research campus and rents approximately 1,300 square met...

CoDa Therapeutics is a clinical stage biotechnology company focused on developing novel targeted therapies that address major unmet medical needs in inflammation, wound-healing and tissue repair. The company is pioneering a new field of science: gap junction modulation, using a new class of therapeutics that can modulate wound responses and reduce inflammation. CoDa has two open INDs and has comp...

Axial Biotherapeutics is a biopharmaceutical company harnessing the link
between the human gut microbiome and the central nervous system to
develop a new class of biotherapeutics to improve the quality of life
for people with neurological diseases and disorders. www.axialbiotherapeutics.com

St. David's Round Rock Medical Center, located adjacent to downtown Round Rock on FM 620, off of IH-35, provides comprehensive health services to residents of Williamson and surrounding counties. Services include The Heart and Vascular Center with express testing, inpatient capacity of 184 beds with private rooms, The Women's Center and a thriving Emergency Room. The medical staff at St. David's R...

Symphogen A/S, the biotech company pioneering recombinant human polyclonal antibodies for the treatment and prevention of human disease, today announced the initial closing of a USD 25 million Series D financing at a premium to the last financing round.

St. David's Round Rock Medical Center, located in Round Rock at 2400 Round Rock Avenue, is owned by St. David's HealthCare, one of the largest health systems in Texas. With more than 170 beds, this acute care hospital provides comprehensive health services to residents of Williamson County and the surrounding areas. Services include The Heart and Vascular Center with express testing, maternity and...

NaPro BioTherapeutics, Inc. is a natural product pharmaceutical company focused primarily on the development, manufacture and commercializa tion of paclitaxel, a naturally-occurring anti-cancer agent found in certain species of yew (Taxus) trees.

SCIVENT is your competent partner for the planning, organization, and realization of conferences business meetings round table discussions lecture series product introductions employee or customer trainingWith SCIVENT, you can concentrate completely on your most important tasks. Scivent develops and markets your ideas and concepts for new conferences and events.

Sephos Biotherapeutics is a privately owned company focused on designing
drugs for the treatment of cancer stem cells where the structure and
biological activity of the drugs have been carefully modeled from
studies of basic cellular mechanisms.

Lewis & Clark Ventures, a newly formed venture fund in St Louis founded
by Tom Hillman,Â helps high potential innovators throughout the Midwest
to build great companies by guiding them through their business
expansion and by providing series A and B round venture capital. For
more information, visit http://lewisandclarkventures.com.

Rodin Therapeutics is discovering and developing first in class
therapeutics for cognitive disorders, applying unique insights into the
role of epigenetics and best in class structural biology capabilities.
Rodin closed a $12.9m Series A financing round in May 2014, and was
co-founded in 2013 by Atlas Venture and Proteros Biostructures.

Talecris Biotherapeutics (Nasdaq: TLCR) is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disorders in a variety of therapeutic areas including immunology, pulmonology, neurology and hemostasis. (http://www.talecris.com/)

Talecris Biotherapeutics (Nasdaq: TLCR) is a global biotherapeutic and
biotechnology company that discovers, develops and produces critical
care treatments for people with life-threatening disorders in a variety
of therapeutic areas including immunology, pulmonology, neurology and
hemostasis. (www.talecris.com)

Talecris Biotherapeutics is a global biotherapeutic and biotechnology
company that discovers, develops and produces critical care treatments
for people with life-threatening disorders in a variety of therapeutic
areas including immunology, pulmonology, neurology and hemostasis. For
more information, please visit: www.talecris.com.

The commercial focus of De Novo is the exploitation of human genomics in drug discovery through in silico drug design. The company attracted £2 million financing in a first VC-backed investment round in April 2000, followed by a second round of funding of £16.75 million in July 2001. Investors in the first round included Avlar Bioventures, Prelude Technology and Cambridge Research and Innovati...

Trinity Biosystems, Inc., was founded in 2002 to commercialize a unique platform technology originally developed at the NIH/NCI. The company received its initial seed financing in 2002 in a Series A round led by Sanderling Ventures.The Founder and Chief Scientific Officer, Randy Mrsny, Ph.D., has more than 20 years experience in research and development and has worked at ALZA and Genentech. He is ...

Best known for being the Oregon-based race event management company that
brought Hood to Coast Relay to the masses, the Better Series now
consists of seven running and one cycling events. The race series
stretches from May through November, and features well-known events such
as Hippie Chick Quarter & Half Marathon Run & Walk; Reach the Beach;
Helvetia Hal...

LifeMax Laboratories, Inc. (www.lifemaxlabs.com),
a wholly-owned subsidiary of LifeMax Healthcare International
Corporation (www.lifemaxhealthcare.com),
is a clinical-stage biotech company focused on treating diseases with
few or no therapeutic options. LifeMax is applying its expertise and
in-depth experience with drug development and commercialization to...

TILT Biotherapeutics is the leading company globally working in the area
of enabling tumor T-cell therapy (including checkpoint antibodies) with
oncolytic viruses. The companyâs patented technology is uniquely based
on human observations on the effect of oncolytic adenoviruses on the
adaptive immune system. www.tiltbio.com

GTC Biotherapeuticsâ core technology enables the development and
manufacture of therapeutic proteins produced through transgenic animal
technology. ATrynÂ®, GTCâs recombinant human antithrombin, has
been approved for use in the United States and Europe. ATryn is the
first and only therapeutic product produced in transgenic animals to be
approve...

Pieris was established in January 2001 with the vision of commercially exploiting technologies developed originally by Prof. Dr. Arne Skerra, Head of the Department of Biological Chemistry at the Technical University of Munich (TUM), Germany. While the scientific excellence of Prof. Dr. Skerra and his fellow Pieris co-founders has long been recognized by the academic community, the product commerc...

REMD Biotherapeutics is a privately held, clinical-stage biotechnology
company focused on creating and developing innovative protein-based
therapies to treat metabolic diseases and other serious illnesses. The
Company was founded by two former Amgen research scientists and has
facilities in Camarillo, California and Beijing China (Cosci-REMD
Biotherapeutic...